WallStreetZenWallStreetZen

NASDAQ: MPLT
Maplight Therapeutics Inc Stock Ownership - Who owns Maplight Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Maplight Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Catalyst4 Inc10% Owner2025-10-285,441,176$17.00
$92.50MBuy
Holdings A. Novo10% Owner2025-10-28952,941$17.00
$16.20MBuy

1 of 1

MPLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MPLT insiders and whales buy or sell their stock.

MPLT Shareholders

What type of owners hold Maplight Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Catalyst4 Inc47.55%19,697,464$325.99MInsider
Holdings A. Novo8.90%3,686,622$61.01MInsider
Robert C. Malenka1.04%431,343$7.14MInsider
Christopher A. Kroeger0.80%330,778$5.47MInsider
Erin Pennock Foff0.12%48,275$798.95kInsider
Vishwas Setia0.10%43,367$717.72kInsider
Anatol Kreitzer0.09%35,953$595.02kInsider
James Woodruff Lillie0.08%32,539$538.52kInsider
Jonathan Gillis0.07%30,565$505.85kInsider
Kristopher Hanson0.07%27,098$448.47kInsider

1 of 2

MPLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AAPG0.02%0.00%
AARD41.09%47.08%Net BuyingNet Buying
ABUS29.81%70.19%Net Selling
ABVC1.56%89.32%
ABCL36.06%44.65%Net Buying
View Top Biotech Stocks

Maplight Therapeutics Stock Ownership FAQ

Who owns Maplight Therapeutics?

Maplight Therapeutics (NASDAQ: MPLT) is owned by 0.00% institutional shareholders, 49.94% Maplight Therapeutics insiders, and 50.06% retail investors. Catalyst4 Inc is the largest individual Maplight Therapeutics shareholder, owning 19.70M shares representing 47.55% of the company. Catalyst4 Inc's Maplight Therapeutics shares are currently valued at $325.99M.

If you're new to stock investing, here's how to buy Maplight Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.